Tina Roy, MD

Tina Roy, MD, is a hematologist-oncologist who provides comprehensive care for patients with cancer and blood disorders. She has a particular clinical interest in lung cancer and the use of targeted therapies, immunotherapy, and other personalized treatment approaches. Dr. Roy completed her fellowship training in Hematology and Oncology at MedStar Georgetown University Hospital. Before fellowship, […]
Ellery Altshuler, MD

Ellery Altshuler, MD completed fellowship training in Hematology and Medical Oncology at Johns Hopkins Medicine after earning his medical degree and completing his residency in Internal Medicine at the University of Florida College of Medicine. Dr. Altshuler has contributed to academic and research initiatives focused on clinical trials, most recently on KRAS inhibitor studies across […]
Thoracic / Lung

Thoracic / Lung Cancer This section will cover non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and mesothelioma. A diagnosis of lung cancer can feel overwhelming, but understanding the disease, how it is diagnosed, and the treatment options available can help you make informed decisions about your care. Advances in cancer treatment, including […]
New OncoTalks Episode: Advancing Biomarker Testing in NSCLC – Dr. Alexander I. Spira, MD, PhD, FACP, FASCO

Virginia Cancer Specialists is pleased to share a new episode of OncoTalks featuring our own Dr. Alexander I. Spira, MD, PhD, FACP, FASCO—Co-Director of the Virginia Cancer Specialists Research Institute and Director of the Thoracic and Phase I Program. In this episode, host Dr. Ira Zackon joins Dr. Spira for an in-depth discussion on the […]
Virginia Cancer Specialists Expands Lung Cancer and Thoracic Oncology Program, Welcomes Thoracic Surgeon Christopher R. Johnson, MD

Fairfax, VA – November 25, 2025 — Virginia Cancer Specialists, the region’s leading comprehensive cancer care provider and ranked the #1 cancer practice in Virginia, is pleased to announce the addition of Christopher R. Johnson, MD, to its distinguished team of thoracic surgeons. Dr. Johnson will begin seeing patients in Fairfax and will have surgical […]
Christopher R. Johnson, MD

Dr. Christopher R. Johnson is board certified in general surgery and has completed fellowship training in thoracic surgery. In 2025, he joined Virginia Cancer Specialists with over a decade of clinical and research experience. He has a special interest in robotic thoracic surgery, lung cancer care, and minimally invasive surgical techniques. Dr. Johnson earned his […]
Improved Survival with a Chemotherapy Free Option for EGFR Mutated Lung Cancer

Living with advanced non–small cell lung cancer (NSCLC) driven by mutations in the EGFR gene can feel overwhelming. For many patients, treatment has meant targeted therapy with the gold standard osimertinib, an oral targeted therapy directed toward the EGFR mutated tumor cells. Data from the large MARIPOSA trial published in September 2025 in The New […]
New Treatment Breakthrough: Amivantamab Plus Lazertinib for Advanced Lung Cancer – Timothy A. McCarthy, MD

A groundbreaking study published in June 2024 in The New England Journal of Medicine has introduced a promising new treatment for a specific type of advanced lung cancer. The research, co-authored by Alex Spira, MD, PhD, FACP, FACSO, Medical Oncologist and Co-Director of The Virginia Cancer Specialists Research Institute, highlights the combination of two drugs, […]
Lung Cancer Awareness Month
Enhancing Lung Cancer Treatment: The Promise of Perioperative Immunotherapy – Samantha DiBenedetto, MD

Introduction: Lung cancer remains one of the most challenging and life-threatening diseases; however, several exciting treatment advances show promising benefits. A recent study in which Virginia Cancer Specialists participated under the research leadership of Dr. Alex Spira, the AEGEAN trial, was published in the New England Journal of Medicine (NEJM) earlier this month and has shed light […]